Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

News Daily News

Anatomic Disease After PCI Linked With Worse Outcomes: VA CART

Michael O'Riordan

December 22, 2022

News Daily News

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Michael O'Riordan

December 14, 2022

News Daily News

Slight Risk of Interstitial Lung Disease Seen With Certain DOACs

Todd Neale

November 23, 2022

News Conference News AHA 2022

RESPECT-EPA: Missed Primary Endpoint but Hints of Benefit With Icosapent Ethyl

Todd Neale

November 10, 2022

News Conference News AHA 2022

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Michael O'Riordan

November 05, 2022

News Daily News

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Michael O'Riordan

October 20, 2022

News Daily News

Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use

L.A. McKeown

October 05, 2022

News Conference News TCT 2022

Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus

Yael L. Maxwell

September 16, 2022

News Conference News ESC 2022

CV Care Around Noncardiac Surgery: New ESC Guidelines

Michael O'Riordan

September 07, 2022

News Conference News ESC 2022

INVICTUS: More Deaths, Stroke With Rivaroxaban in Rheumatic Heart Disease AF

Michael O'Riordan

August 28, 2022

News Conference News ESC 2022

ALL-HEART: Gout Drug Allopurinol No Help in CV Prevention

Shelley Wood

August 27, 2022

News Conference News ESC 2022

Polypill Bests Usual Care in Patients With Recent MI: SECURE

Michael O'Riordan

August 26, 2022

News Opinion Editor's Corner ESC 2022

What’s Going to Be Hot at ESC 2022?

Shelley Wood

August 22, 2022

News Daily News

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

Michael O'Riordan

August 16, 2022

News

‘Less Is More’ for Patients With AF and Stable CAD: AFIRE Analysis

Todd Neale

June 17, 2022

News Conference News EuroPCR 2022

Registry Data Hint at MACE Benefit With Renal Denervation

Michael O'Riordan

May 17, 2022

News Daily News

Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV

Michael O'Riordan

May 09, 2022

News Daily News

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

Michael O'Riordan

March 30, 2022

More Evidence Links Breast Arterial Calcification and CVD Risk

News Daily News

March 2022 News Roundup

L.A. McKeown

March 01, 2022

Advertisement

Anatomic Disease After PCI Linked With Worse Outcomes: VA CART

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Slight Risk of Interstitial Lung Disease Seen With Certain DOACs

RESPECT-EPA: Missed Primary Endpoint but Hints of Benefit With Icosapent Ethyl

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Apixaban Tops Rivaroxaban in AF Patients With Valve Disease, Claims Data Suggest

Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use

Primordial Prevention Before End-stage CVD: Experts Call for a Fresh Focus

CV Care Around Noncardiac Surgery: New ESC Guidelines

INVICTUS: More Deaths, Stroke With Rivaroxaban in Rheumatic Heart Disease AF

ALL-HEART: Gout Drug Allopurinol No Help in CV Prevention

Polypill Bests Usual Care in Patients With Recent MI: SECURE

What’s Going to Be Hot at ESC 2022?

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

‘Less Is More’ for Patients With AF and Stable CAD: AFIRE Analysis

Registry Data Hint at MACE Benefit With Renal Denervation

Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

More Evidence Links Breast Arterial Calcification and CVD Risk

March 2022 News Roundup

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content